When a serious injury tears away a large chunk of muscle, the body usually fills the gap with scar. In animals, an engineered collagen scaffold instead helped grow real, working muscle there.
This article covers emerging musculoskeletal and regenerative-medicine research. It reflects what may be coming in the field, not the treatments ADX or its network physicians currently provide.
Why It Matters
When an accident, surgery, or other serious trauma rips away a large piece of muscle, the body usually cannot grow it back. Instead it fills the gap with scar tissue, which leaves people weaker, stiffer, and often in lasting pain. Researchers have now tested a new material that may help the body rebuild real, working muscle in that gap instead of scar. The early results come from animals, not people, but they point to a possible new way to treat some of the hardest muscle injuries.
Summary
Doctors call this kind of injury volumetric muscle loss, or VML. It happens when so much muscle is destroyed that the body’s normal repair system is overwhelmed. Today’s main options are surgeries that move muscle from another part of the body, but these are complex and often restore only part of a person’s strength. A team led by researchers at Purdue University set out to test whether a specially engineered scaffold could do better, publishing their findings in March 2026 in the peer-reviewed journal Scientific Reports.
The scaffold is built from “Oligomer,” a purified, engineered form of type I collagen, the same protein that gives natural tissue its structure. Working in a rat model, the researchers surgically removed about 30 percent of a leg muscle to create a VML injury, then filled the gap with one of three versions of the material: a liquid form that hardens in place, a softer pre-formed implant, and a denser pre-formed implant. Some injuries were left untreated for comparison. Over the following weeks and months, the team measured how much muscle came back, how strong it was, and what kind of tissue formed inside the wound.
The treated muscles regrew in an organized way that untreated injuries did not. The scaffolds supported the return of aligned muscle fibers along with new blood vessels and nerves, the supporting network that working muscle needs. The denser implant held the wound’s shape best and led to the greatest recovery of muscle mass and contractile strength. A detailed genetic analysis of the healing tissue showed that the scaffold encouraged a “regenerative” response, drawing in the body’s own repair cells, rather than the inflammation-driven scarring that normally follows this kind of injury.
These results are an early, preclinical step, and animal findings do not always carry over to humans. Still, they help explain how the material guides healing toward muscle instead of scar, and a related in-place version of this collagen technology has already received FDA clearance for wound care, which may ease the path toward future human studies. If the approach holds up in clinical trials, an off-the-shelf scaffold that helps the body regrow muscle could one day give patients with severe muscle loss a better chance at real recovery.
Source: Scientific Reports, Morrison et al., 2026 – https://doi.org/10.1038/s41598-026-42993-z
Research compiled by ADX AI Agent, reviewed by Sean Gallivan